http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0912449-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate | 1995-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4db3084600046ef246682b0a36e50b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3973b5fc5d80699b1fb25b8171db328e |
| publicationDate | 1997-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0912449-A |
| titleOfInvention | Patch |
| abstract | (57) [Summary] [Structure] An adhesive patch containing indomethacin, wherein propylene glycol and a dihydric alcohol having 4 to 6 carbon atoms are used in combination. [Effects] According to the present invention, it is possible to enhance the transdermal absorbability of indomethacin, which has conventionally been poor in transdermal absorbability, to the patch base, and to maximize its pharmacological action. Moreover, according to the present invention, indomethacin, which causes side effects such as digestive disorders when administered orally, can be efficiently transdermally administered directly to the affected area, and in this respect also contributes to the safety of treatment. is there. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7074234-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002029971-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6824557-B2 |
| priorityDate | 1995-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.